Brady W. Dougan - 13 Jun 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director, 10%+ Owner
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
13 Jun 2023
Net transactions value
-$12,675,000
Form type
4
Filing time
15 Jun 2023, 16:19:31 UTC
Previous filing
26 May 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale $12,675,000 -4,875,000 -32% $2.60 10,490,736 13 Jun 2023 By Ayabudge LLC F1
holding HUMA Common Stock 510,161 13 Jun 2023 Direct
holding HUMA Common Stock 1,270,240 13 Jun 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.